57 research outputs found

    Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>All the peroxisome proliferator activated receptors (PPARs) are found to be expressed in bone cells. The PPARγ agonist rosiglitazone has been shown to decrease bone mass in mice and thiazolidinediones (TZDs) have recently been found to increase bone loss and fracture risk in humans treated for type 2 diabetes mellitus. The aim of the study was to examine the effect of the PPARα agonist fenofibrate (FENO) and the PPARγ agonist pioglitazone (PIO) on bone in intact female rats.</p> <p>Methods</p> <p>Rats were given methylcellulose (vehicle), fenofibrate or pioglitazone (35 mg/kg body weight/day) by gavage for 4 months. BMC, BMD, and body composition were measured by DXA. Histomorphometry and biomechanical testing of excised femurs were performed. Effects of the compounds on bone cells were studied.</p> <p>Results</p> <p>The FENO group had higher femoral BMD and smaller medullary area at the distal femur; while trabecular bone volume was similar to controls. Whole body BMD, BMC, and trabecular bone volume were lower, while medullary area was increased in PIO rats compared to controls. Ultimate bending moment and energy absorption of the femoral shafts were reduced in the PIO group, while similar to controls in the FENO group. Plasma osteocalcin was higher in the FENO group than in the other groups. FENO stimulated proliferation and differentiation of, and OPG release from, the preosteoblast cell line MC3T3-E1.</p> <p>Conclusion</p> <p>We show opposite skeletal effects of PPARα and γ agonists in intact female rats. FENO resulted in significantly higher femoral BMD and lower medullary area, while PIO induced bone loss and impairment of the mechanical strength. This represents a novel effect of PPARα activation.</p

    MS_HistoneDB, a manually curated resource for proteomic analysis of human and mouse histones

    Get PDF

    Step growth in single crystal diamond grown by microwave plasma chemical vapor deposition

    No full text
    Single crystal diamond films of varying quality are deposited using microwave plasma chemical vapor deposition (MPCVD) apparatus. Unpolished natural diamond seeds are used as substrates in the temperature (T-s) range 850-1200 degrees C. The gas mixture of methane (CH4), hydrogen (H,) and oxygen (0,) is used for the deposition of diamond. The deposition pressure is varied in the range 90 to 150 Torr. The films are characterized using scanning electron microscopy (SEM), Atomic force microscopy (AFM) and Raman spectroscopy techniques. The growth morphology of the films is found to be a sensitive function of the deposition parameters. The crystalline nature of the films change from polycrystalline to single crystal as we increase T, and for a certain set of parameters the filamentary growth of the diamond crystals can be seen. The films are polycrystalline in the range Of substrate temperature 850-900 degrees C and oriented grains of diamond crystals arc evident as the T, increases. The single crystal diamond growth is observed to proceed via the step growth mechanism with the evidence of bunching of the steps. Our study explores evolution of the growth of single crystal diamond in a wide range of parameters. (c) 2005 Elsevier B.V. All rights reserved
    corecore